Close Server: KOPWWW05 | Not logged in


Welcome to Health Care POV | sign in | join

BROWSE BY TAGS

ADVANCE Perspective: Respiratory Views

FDA Approves Symbicort For Treatment of Asthma in Pediatric Patients
February 3, 2017 11:42 AM by ADVANCE for Respiratory Care & Sleep Medicine
In major news for pediatric asthma patients, AstraZeneca this week announced that the U.S. Food and Drug Administration (FDA) approved SYMBICORT® (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol 80/4.5 micrograms for the treatment of asthma Read More...
0 comments »     
OSA: Deadly Consequences
January 27, 2017 12:04 PM by ADVANCE for Respiratory Care & Sleep Medicine
In October 2016, New Jersey Transit issued a policy change addressing engineers who suffer from sleep apnea, the Associated Press reported on Nov. 21. On Sept. 29, a train crash in Hoboken, N.J. killed one and injured more than 100 and obstructive sleep Read More...
0 comments »     
Study: Omega-3 Fatty Acids May Reduce Asthma Risk in Children
December 29, 2016 1:41 PM by ADVANCE for Respiratory Care & Sleep Medicine
By ADVANCE Perspectives According to a study published in The New England Journal of Medicine , researchers have found taking certain omega-3 fatty acids during pregnancy reduces the risk of the child developing asthma by nearly one-third. The study from Read More...
0 comments »     
A Trial of Clinical Trials
December 2, 2016 12:26 PM by ADVANCE for Respiratory Care & Sleep Medicine
By Sarah Sutherland Exciting news for clinical trial researchers! The days of spending more time figuring out how to use your electronic data capture (EDC) — rather than actually conducting research — could be troubles of the past. Recently, Porter Research, Read More...
1 comments »     
ResMed Launches AirView Action Groups
November 14, 2016 10:54 AM by ADVANCE for Respiratory Care & Sleep Medicine
ResMed has announced two enhancements to AirView, the world’s largest cloud-based remote patient monitoring platform that enables care teams to securely access therapy data from three million sleep apnea and respiratory care patients every day. AirView Read More...
0 comments »     
Spyryx Biosciences Presents Data on SPX-101
November 4, 2016 8:48 AM by ADVANCE for Respiratory Care & Sleep Medicine
By Tamer Abouras There is big news pertaining to Cystic Fibrosis (CF) coming out of the 2016 North American Cystic Fibrosis Conference (NACFC), where three posters presented by Spyryx Biosciences provided data demonstrating the safety, stability and efficacy Read More...
0 comments »     
Data from Phase 1 Trial of Triplex Vaccine for Control of Cytomegalovirus Published in Blood
October 28, 2016 11:51 AM by ADVANCE for Respiratory Care & Sleep Medicine
By ADVANCE Perspectives Duarte, CA and New York, NY — City of Hope and Helocyte, Inc., a majority-owned subsidiary of Fortress Biotech, Inc. has announced that data from the Phase 1 trial of Helocyte’s Triplex vaccine were published online this month Read More...
0 comments »     
BD and Vancive Medical Technologies Launch New Vascular Dressings with CHG Antimicrobial
September 16, 2016 12:43 PM by ADVANCE for Respiratory Care & Sleep Medicine
By ADVANCE Perspectives Big news from BD ! The company, along with Vancive Medical Technologies , has launched a line of transparent vascular dressings with chlorhexidine gluconate (CHG) antimicrobial preservative that are designed to enhance patient Read More...
0 comments »     
Philips Announces Sponsorship of COPD Documentary
September 2, 2016 7:52 AM by ADVANCE for Respiratory Care & Sleep Medicine
By Tamer Abouras Live long and prosper! Royal Philips has announced its sponsorship of the documentary, “COPD: Highly Illogical - Remembering Leonard Nimoy.” The documentary seeks to educate viewers about chronic obstructive pulmonary disease (or COPD) Read More...
0 comments »     
ECMO Market Size Projected to Reach $346.1 Million by 2024
August 18, 2016 9:14 AM by ADVANCE for Respiratory Care & Sleep Medicine
By ADVANCE Perspectives The extracorporeal membrane oxygenation market is expected to reach $346.1 million by 2024, according to a new report by Grand View Research, Inc. The growing number of respiratory failure cases and conditions, such as cardiopulmonary Read More...
0 comments »     
Q&A with Eli Diacopoulos from Philips Respironics
August 4, 2016 9:31 AM by ADVANCE for Respiratory Care & Sleep Medicine
By Tamer Abouras Philips Respironics recently announced exciting news about their SimplyGo Mini portable oxygen concentrator, which now conforms to all applicable Federal Aviation Administration (FAA) requirements for in-flight use. ADVANCE had the opportunity Read More...
0 comments »     
Philips' Care Orchestrator to Connect Trilogy Ventilators for Patients with COPD
July 21, 2016 2:01 PM by ADVANCE for Respiratory Care & Sleep Medicine
By ADVANCE Perspectives From PRNewswire, some exciting news about portable ventilation from Philips Respironics . Philips Respironics has announced that its Trilogy family of portable ventilators, the most widely used ventilators in North America, will Read More...
0 comments »     
New Opioid Use Among Older Adults with COPD Linked to Increased Risk for Respiratory-Related Death
July 14, 2016 1:18 PM by ADVANCE for Respiratory Care & Sleep Medicine
By Tamer Abouras (News-Medical.net) — Older adults with chronic obstructive pulmonary disease who start using opioids have a more than two-fold higher risk of dying from a respiratory-related complication compared to non-opioid users, St. Michael's Hospital Read More...
1 comments »     
Potential Respiratory Syncytial Virus Vaccine on the Way from Vaxart
June 30, 2016 2:02 PM by ADVANCE for Respiratory Care & Sleep Medicine
By Tamer Abouras ADVANCE has covered respiratory syncytial virus (RSV) consistently in the past year. Any why wouldn’t we? RSV is a major cause of severe respiratory infection in the elderly, in immunocompromised patients and in adults with other underlying Read More...
0 comments »     
GSK’s Triple-COPD Trial a Success
June 20, 2016 12:28 PM by ADVANCE for Respiratory Care & Sleep Medicine
By Tamer Abouras From Digital Look , some exciting — and relieving news — for GlaxoSmithKline. European and U.S. regulatory submissions are likely to be completed the end of 2016 based on the data from this Phase III clinical test by GSK and its regular Read More...
0 comments »     

Search

About this Blog

Keep Me Updated